Clinical Trial Update: A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis [Phase 1]

View source ↗

Summary

A Phase 1 clinical pharmacology study of KHK4827 in healthy volunteers and patients with moderate to severe psoriasis, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• KHK4827

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED